Genomic Valley Biotech Board Meeting on Aug 14 to Approve Unaudited Results

Genomic Valley Biotech Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ending June 30, 2026. Additionally, the meeting will address any other business as permitted by the chairman. In compliance with SEBI regulations, the trading window for company securities will be closed from July 1, 2026, until 48 hours after the results are publicly disclosed, affecting directors, KMPs, promoters, and designated persons.